Unlisted Deals:
×

Wellness Forever Medicare Annual Reports, Balance Sheet and Financials

Last Traded Price 980.00 + 0.00 %

Wellness Forever Medicare Limited (Wellness Forever) Return Comparision with Primex 40 Index

Periods 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years All Time
Primex-40
Wellness Forever Medicare Limited

Wellness Forever Medicare Limited Consolidated Balance Sheet (Rs in Crores)

Particulars

31-03-2026

31-03-2025

Non-Current Assets

 

 

Property, Plant And Equipment

43.28

56.88

Right-Of-Use Assets

212.76

225.91

Capital Work In Progress

0.11

0.54

Intangible Assets

4.33

7.12

Intangible Assets Under Development

0.16

0.09

Financial Assets - Loans

0.42

0.05

Financial Assets - Other Financial Assets

65.55

47.17

Income Tax Assets (Net)

5.78

3.04

Deferred Tax Assets (Net)

54.41

45.34

Other Non-Current Assets

3.31

3.12

Current Assets

 

 

Inventories

217.52

225.00

Financial Assets - Trade Receivables

67.13

47.28

Financial Assets - Cash And Cash Equivalents

32.43

22.73

Financial Assets - Bank Balances Other Than Above

28.36

18.10

Financial Assets - Loans

0.19

0.95

Financial Assets - Other Financial Assets

21.23

16.73

Other Current Assets

15.35

11.57

Total Assets

772.32

731.59

Equity

 

 

Equity Share Capital

11.16

11.16

Instruments Entirely Equity In Nature

25.00

-

Other Equity

191.13

205.41

Non-Current Liabilities

 

 

Financial Liabilities - Borrowings

19.56

13.49

Financial Liabilities - Lease Liabilities

166.79

163.79

Provisions

11.95

7.80

Current Liabilities

 

 

Financial Liabilities - Borrowings

109.15

109.08

Financial Liabilities - Lease Liabilities

69.71

77.84

Trade Payables - Micro And Small Enterprises

12.24

9.33

Trade Payables - Other Than Micro And Small Enterprises

138.55

104.69

Other Financial Liabilities

5.86

17.51

Other Current Liabilities

8.01

8.99

Provisions

3.22

2.51

Total Equity And Liabilities

772.32

731.59

 

Wellness Forever Medicare Limited Consolidated Profit & Loss Statement (Rs in Crores)

Particulars

31-03-2026

31-03-2025

Income

 

 

Revenue from operations

1,663.38

1,562.05

Other income

9.71

9.18

Total income

1,673.08

1,571.22

Expenses

 

 

Purchases of stock-in-trade

1,194.04

1,144.69

Changes in inventories of stock-in-trade

7.48

-15.83

Employee benefits expense

193.17

184.88

Finance costs

38.34

37.54

Depreciation and amortisation expenses

115.88

119.56

Other expenses

147.41

157.21

Total expenses

1,696.30

1,628.05

Loss before tax

-23.22

-56.82

Deferred tax

-8.50

-9.41

Loss for the year

-14.72

-47.42

Other comprehensive income

 

 

Remeasurement of net defined benefit plan

-2.29

-1.34

Income tax relative to above

0.57

0.34

Total comprehensive loss for the year

-16.44

-48.41

Earnings per equity share

 

 

Basic & Diluted

-2.64

-8.50

 

Wellness Forever Medicare Limited Consolidated Cash Flow Statement (Rs in Crores)

Particulars

31-03-2026

31-03-2025

Cash flows from operating activities

 

 

Loss before tax

-23.22

-56.82

Adjustments for:

 

 

Finance costs

38.34

37.54

Interest income

-6.47

-6.11

Interest on Income Tax refund

-

-0.63

Loss on disposal of property, plant and equipment (net)

1.50

3.35

Depreciation and amortisation expenses

115.88

119.56

Employee share-based payment expense

2.12

3.29

Loss allowances

0.62

6.13

Gain on termination of lease

-1.10

-1.37

Net gain on redemption of mutual fund

-0.06

-0.12

Operating cash flows before movement in working capital

127.60

104.82

(Increase)/decrease in operating assets

 

 

Trade receivables

-20.47

5.35

Inventories

7.48

-15.83

Other financial assets

2.22

-4.70

Other assets

-4.26

3.72

Increase/(decrease) in operating liabilities

 

 

Trade payables

36.76

64.38

Provisions

2.58

2.86

Other financial liabilities

-11.82

-0.45

Other current liabilities

-0.98

1.51

Changes in working capital

11.50

56.83

Cash generated from operations

139.11

161.65

Income taxes paid (net of refund)

-2.74

4.85

Net cash generated from operating activities

136.37

166.50

Cash flows from investing activities

 

 

(Investment in)/proceeds from redemption of deposit with banks (net)

-35.62

-13.82

(Investment in)/proceeds from redemption of mutual funds (net)

0.06

8.13

Loan given to/(repaid by) employees (net)

0.38

-0.22

Interest received

1.55

1.46

Purchase of property, plant and equipment and other intangible assets

-9.51

-13.51

Proceeds on disposal of property, plant and equipment

0.43

0.92

Net cash used in investing activities

-42.71

-17.05

Cash flows from financing activities

 

 

Proceeds from issue of instruments entirely equity in nature incl. securities premium

25.00

-

Proceeds from issue of equity shares including securities premium

0.16

0.72

Proceeds/(repayment) of long term borrowings

-5.96

-17.20

Proceeds from liability towards failed sale and lease back transaction

7.39

-

Repayment of liability towards failed sale and lease back transaction

-0.65

-

Repayment of short term borrowings (net)

5.89

-30.42

Principal repayment of lease liabilities

-77.45

-80.18

Interest paid on lease liabilities

-22.61

-21.33

Interest paid

-14.88

-15.85

Interest paid on liability towards failed sale and lease back transaction

-0.84

-

Net cash (used in)/generated by financing activities

-83.96

-164.25

Net increase/(decrease) in cash and cash equivalents

9.70

-14.79

Cash and cash equivalents at the beginning of the year

22.73

37.52

Cash and cash equivalents at the end of the year

32.43

22.73


Summary of Cash Flow Statement for the years 2026 and 2025:

Cash Flow from Operating Activities: The company reported net cash generated from operating activities of Rs. 136.37 crores in FY 2025-26, compared to Rs. 166.50 crores in FY 2024-25, indicating a decline in operating cash flow. Although the loss before tax reduced significantly from Rs. 56.82 crores to Rs. 23.22 crores, operating cash flows before working capital movements improved from Rs. 104.82 crores to Rs. 127.60 crores. However, changes in working capital contributed Rs. 11.50 crores during FY 2025-26, compared to Rs. 56.83 crores in the previous year. Higher trade receivables and other asset-related cash outflows partly offset the benefits from increased trade payables. Overall, the company maintained positive operating cash flows, reflecting its ability to generate cash from its core business operations.

 

Cash Flow from Investing Activities: The company reported net cash used in investing activities of Rs. 42.71 crores in FY 2025-26, compared to Rs. 17.05 crores in FY 2024-25, indicating higher investment-related cash outflows. The major cash outflow was Rs. 35.62 crores towards net investment in bank deposits, while Rs. 9.51 crores was spent on purchasing property, plant and equipment and other intangible assets. The company also received interest income of Rs. 1.55 crores and proceeds from the disposal of fixed assets amounting to Rs. 0.43 crores. Overall, the increased investing outflow indicates greater allocation of funds towards bank deposits and business-related investments during the year.

 

Cash Flow from Financing Activities: The company reported net cash used in financing activities of Rs. 83.96 crores in FY 2025-26, compared to Rs. 164.25 crores in FY 2024-25, reflecting a substantial reduction in financing-related cash outflows. During the year, the company raised Rs. 25.00 crores through the issue of instruments entirely equity in nature and received Rs. 7.39 crores from a liability related to a failed sale and leaseback transaction. It also recorded a net repayment of long-term borrowings of Rs. 5.96 crores. Significant cash outflows included principal repayment of lease liabilities of Rs. 77.45 crores, interest paid on lease liabilities of Rs. 22.61 crores and other interest payments. Overall, the lower financing outflow indicates an improvement in the company 's financing cash position, supported by fresh capital raised and reduced repayment of borrowings.

 

Net Increase/(Decrease) in Cash and Cash Equivalents: The company recorded a net increase in cash and cash equivalents of Rs. 9.70 crores in FY 2025-26, compared to a net decrease of Rs. 14.79 crores in FY 2024-25. Consequently, cash and cash equivalents increased from Rs. 22.73 crores at the beginning of the year to Rs. 32.43 crores at the end of FY 2025-26. The positive cash balance reflects the company 's ability to generate sufficient operating cash flows to meet its investing and financing requirements while improving its overall cash position. Overall, the company demonstrated an improvement in cash flow management during FY 2025-26, despite lower operating cash generation and higher investing outflows.

 

Financial ratios of Wellness Forever Medicare Limited 

Particulars

31-03-2026

31-03-2025

Current Ratio

1.11

1.04

Debt-Equity Ratio

0.46

0.44

Debt Service Coverage Ratio

0.87

0.56

Return on Equity

-0.08

-0.22

Inventory Turnover Ratio

5.46

5.30

Trade Receivables Turnover Ratio

28.67

27.06

Trade Payables Turnover Ratio

10.67

13.84

Net Capital Turnover Ratio

45.75

129.00

Net Profit Margin

-0.01

-0.04

Return on Capital Employed

-0.03

-0.16

Return On Investment

0.06

0.07


Summary of Financial Ratios for the year 2026 and 2025:

Current Ratio: The current ratio increased from 1.04 in FY 2024-25 to 1.11 in FY 2025-26, indicating a slight improvement in the company 's short-term liquidity position. However, the ratio remains below the generally preferred benchmark of 2:1, suggesting that the company may have limited capacity to meet its short-term obligations.

 

Debt-Equity Ratio: The debt-equity ratio increased marginally from 0.44 in FY 2024-25 to 0.46 in FY 2025-26, indicating a slight rise in the company 's dependence on borrowed funds compared to shareholders ' equity. However, the ratio remains relatively moderate, suggesting a reasonable balance between debt and equity financing.

 

Debt Service Coverage Ratio: The debt service coverage ratio improved from 0.56 in FY 2024-25 to 0.87 in FY 2025-26, indicating an improvement in the company 's ability to generate earnings to meet its debt repayment obligations. However, the ratio remains below 1, suggesting that the company 's operating earnings are still insufficient to comfortably cover its debt servicing requirements.

 

Return on Equity: The return on equity improved from -0.22 in FY 2024-25 to -0.08 in FY 2025-26, indicating a reduction in losses relative to shareholders ' equity. Despite the improvement, the negative ratio reflects that the company continues to generate negative returns for its shareholders.

 

Inventory Turnover Ratio: The inventory turnover ratio increased slightly from 5.30 in FY 2024-25 to 5.46 in FY 2025-26, indicating an improvement in inventory management and the efficiency of stock movement. This suggests that the company has become slightly more efficient in converting its inventory into sales during the year.

 

Trade Receivables Turnover Ratio: The trade receivables turnover ratio increased from 27.06 in FY 2024-25 to 28.67 in FY 2025-26, indicating improved efficiency in collecting payments from customers. This reflects better receivables management and a faster collection cycle.

 

Trade Payables Turnover Ratio: The trade payables turnover ratio declined from 13.84 in FY 2024-25 to 10.67 in FY 2025-26, indicating that the company is taking relatively longer to make payments to its suppliers. This may reflect changes in payment practices or greater utilisation of supplier credit.

 

Net Capital Turnover Ratio: The net capital turnover ratio declined significantly from 129.00 in FY 2024-25 to 45.75 in FY 2025-26, indicating a substantial reduction in the efficiency with which the company utilises its working capital to generate revenue. This suggests comparatively lower working capital utilisation efficiency during the year.

 

Net Profit Margin: The net profit margin improved from -0.04 in FY 2024-25 to -0.01 in FY 2025-26, indicating a reduction in losses in relation to revenue. Although the company has moved closer to profitability, the negative margin indicates that it continues to incur net losses.

 

Return on Capital Employed: The return on capital employed improved from -0.16 in FY 2024-25 to -0.03 in FY 2025-26, indicating a significant reduction in losses generated relative to the capital employed. However, the negative ratio suggests that the company has not yet achieved positive returns from its capital investments.

 

Return on Investment: The return on investment declined slightly from 0.07 in FY 2024-25 to 0.06 in FY 2025-26, indicating a marginal decrease in the returns generated from investments. This suggests a slight reduction in investment performance compared to the previous year.

Wellness Forever Medicare Annual Report

Wellness Forever Medicare Annual Report FY 2026

Download
Support Puja Support Ishika Support Purvi

News Alert